Protagonist Therapeutics, Inc. · NASDAQ:PTGX
State Street Corp reported a 5.20% stake in Protagonist Therapeutics, Inc. (Schedule 13G)
Event Jun 30, 2025 · Filed Aug 11, 2025
State Street Corp reported a 5.20% stake in Protagonist Therapeutics, Inc., 3,207,774 shares, as a passive investor on Jun 30, 2025. Filed Aug 11, 2025 (Schedule 13G).
- Stake
- 5.20%
- Shares
- 3,207,774
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| STATE STREET CORPORATION | 5.20% | 3,207,774 |
Source
Related
- Protagonist Therapeutics, Inc.
- State Street Corp
- Protagonist Therapeutics, Inc. shareholders
- Schedule 13G · State Street Corp · Aug 7, 2026
- Schedule 13G · State Street Corp · May 12, 2026
- Schedule 13G · State Street Corp · May 13, 2025
- Form 4 · Ali Asif · Oct 2, 2026
- Form 4 · Patel Dinesh V Ph D · Sep 10, 2026
- Form 4 · Patel Dinesh V Ph D · Sep 8, 2026
- Schedule 13G/A · Farallon Capital Management, L.L.C. · Aug 13, 2026
- Form 4 · Patel Dinesh V Ph D · Aug 12, 2026